Literature DB >> 27929271

Hormone Therapy and Other Treatments for Symptoms of Menopause.

D Ashley Hill1, Mark Crider1, Susan R Hill2.   

Abstract

The results of large clinical trials have led physicians and patients to question the safety of hormone therapy for menopause. In the past, physicians prescribed hormone therapy to improve overall health and prevent cardiac disease, as well as for symptoms of menopause. Combined estrogen/progestogen therapy, but not estrogen alone, increases the risk of breast cancer when used for more than three to five years. Therefore, in women with a uterus, it is recommended that physicians prescribe combination therapy only to treat menopausal symptoms such as vasomotor symptoms (hot flashes) and vaginal atrophy, using the smallest effective dosage for the shortest possible duration. Although estrogen is the most effective treatment for hot flashes, nonhormonal alternatives such as low-dose paroxetine, venlafaxine, and gabapentin are effective alternatives. Women with a uterus who are using estrogen should also take a progestogen to reduce the risk of endometrial cancer. Women who cannot tolerate adverse effects of progestogens may benefit from a combined formulation of estrogen and the selective estrogen receptor modulator bazedoxifene. There is no highquality, consistent evidence that yoga, paced respiration, acupuncture, exercise, stress reduction, relaxation therapy, and alternative therapies such as black cohosh, botanical products, omega-3 fatty acid supplements, and dietary Chinese herbs benefit patients more than placebo. One systematic review suggests modest improvement in hot flashes and vaginal dryness with soy products, and small studies suggest that clinical hypnosis significantly reduces hot flashes. Patients with genitourinary syndrome of menopause may benefit from vaginal estrogen, nonhormonal vaginal moisturizers, or ospemifene (the only nonhormonal treatment approved by the U.S. Food and Drug Administration for dyspareunia due to menopausal atrophy). The decision to use hormone therapy depends on clinical presentation, a thorough evaluation of the risks and benefits, and an informed discussion with the patient.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27929271

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

1.  "Is it menopause or bipolar?": a qualitative study of the experience of menopause for women with bipolar disorder.

Authors:  Tania Perich; Jane Ussher; Chloe Parton
Journal:  BMC Womens Health       Date:  2017-11-16       Impact factor: 2.809

2.  Tox21BodyMap: a webtool to map chemical effects on the human body.

Authors:  Alexandre Borrel; Scott S Auerbach; Keith A Houck; Nicole C Kleinstreuer
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

3.  Sensitivity-to-change and predictive validity of the Cervantes Short-Form (C-SF) questionnaire in postmenopausal women.

Authors:  María Fasero; Javier Rejas-Gutiérrez; Pluvio J Coronado
Journal:  Arch Gynecol Obstet       Date:  2022-09-20       Impact factor: 2.493

4.  Understanding the complex relationships underlying hot flashes: a Bayesian network approach.

Authors:  Rebecca L Smith; Lisa M Gallicchio; Jodi A Flaws
Journal:  Menopause       Date:  2018-02       Impact factor: 2.953

Review 5.  Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review.

Authors:  Riley Bove; Annette Okai; Maria Houtchens; Birte Elias-Hamp; Alessandra Lugaresi; Kerstin Hellwig; Eva Kubala Havrdová
Journal:  Front Neurol       Date:  2021-03-19       Impact factor: 4.003

Review 6.  A Nutraceutical Approach to Menopausal Complaints.

Authors:  Pasquale De Franciscis; Nicola Colacurci; Gaetano Riemma; Anna Conte; Erika Pittana; Maurizio Guida; Antonio Schiattarella
Journal:  Medicina (Kaunas)       Date:  2019-08-28       Impact factor: 2.430

7.  Isoamericanoic Acid B from Acer tegmentosum as a Potential Phytoestrogen.

Authors:  Seoung Rak Lee; Yong Joo Park; Yu Bin Han; Joo Chan Lee; Seulah Lee; Hyun-Ju Park; Hae-Jeung Lee; Ki Hyun Kim
Journal:  Nutrients       Date:  2018-12-04       Impact factor: 5.717

8.  Development of Hormonal Intravaginal Rings: Technology and Challenges.

Authors:  Fojan Rafiei; Hadi Tabesh; Shayan Farzad; Farah Farzaneh; Maryam Rezaei; Fateme Hosseinzade; Khosrow Mottaghy
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-07-13       Impact factor: 2.915

Review 9.  Has knowledge of the vaginal microbiome altered approaches to health and disease?

Authors:  Gregor Reid
Journal:  F1000Res       Date:  2018-04-13

10.  Isoflavones Isolated from the Seeds of Millettia ferruginea Induced Apoptotic Cell Death in Human Ovarian Cancer Cells.

Authors:  Yi-Yue Wang; Jun Hyeok Kwak; Kyung-Tae Lee; Tsegaye Deyou; Young Pyo Jang; Jung-Hye Choi
Journal:  Molecules       Date:  2020-01-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.